Literature DB >> 14711830

Hepatitis C virus core functions as a suppressor of cyclin-dependent kinase-activating kinase and impairs cell cycle progression.

Kazuyoshi Ohkawa1, Hisashi Ishida, Fumihiko Nakanishi, Atsushi Hosui, Keiji Ueda, Tetsuo Takehara, Masatsugu Hori, Norio Hayashi.   

Abstract

We investigated how the hepatitis C virus (HCV) core protein affects the cell cycle profile and cell cycle-related molecules by using the HCV core-expressing stable transfectant. Analysis of the cell cycle profile showed that HCV core impaired G(1) to S transition. The E2F-mediated transcription, phosphorylation of the retinoblastoma protein, and cyclin-dependent kinase (CDK) 4 and CDK2 activities were suppressed in HCV core-expressing cells. The expression levels of G(1) phase-related CDKs/cyclins and various CDK inhibitors were not substantially affected by expression of HCV core. When influences of HCV core on CDK-activating kinase (CAK) were examined, the expression levels of the CAK components, CDK7, cyclin H, and MAT1, were not affected. However, formation of the ternary CAK complex, CAK activity, and the CDK2 level with activating phosphorylation were inhibited by expression of the HCV core. The direct effect of HCV core on CAK was further assessed in the cell-free system by adding the in vitro translated HCV core protein to the anti-CDK7 immunoprecipitate from the cell. The results showed that HCV core led to dissociation of MAT1 from the CAK complex and suppressed the CAK activity. Furthermore, the binding assay revealed that the HCV core was directed against CDK7. Their interaction occurred mainly in the nucleus by the immunostaining. In conclusion, the HCV core protein interacts with CAK and functions as an extrinsic suppressor of CAK. This may be the molecular basis of HCV core-mediated suppression of cell cycle progression. Our findings suggest a novel mechanism concerning HCV core-mediated alteration in the cell cycle machinery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14711830     DOI: 10.1074/jbc.M308560200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain.

Authors:  Wenyu Lin; Sun Suk Kim; Elaine Yeung; Yoshitaka Kamegaya; Jason T Blackard; Kyung Ah Kim; Michael J Holtzman; Raymond T Chung
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Differential stimulation of hepatitis C virus RNA translation by microRNA-122 in different cell cycle phases.

Authors:  Carmen Fehr; K Dominik Conrad; Michael Niepmann
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

3.  Genes transactivated by hepatitis C virus core protein, a microarray assay.

Authors:  Min Liu; Shu-Lin Zhang; Jun Cheng; Yan Liu; Lin Wang; Qing Shao; Jian Zhang; Shu-Mei Lin
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

4.  The wild-type hepatitis C virus core inhibits initiation of antigen-specific T- and B-cell immune responses in BALB/c mice.

Authors:  Wenbo Zhu; Yanzi Chang; Chunchen Wu; Qingxia Han; Rongjuan Pei; Mengji Lu; Xinwen Chen
Journal:  Clin Vaccine Immunol       Date:  2010-06-02

5.  Hepatitis C virus core protein associates with detergent-resistant membranes distinct from classical plasma membrane rafts.

Authors:  Meirav Matto; Charles M Rice; Benjamin Aroeti; Jeffrey S Glenn
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Hepatitis C virus core proteins derived from different quasispecies of genotype 1b inhibit the growth of Chang liver cells.

Authors:  Xue-Bing Yan; Lei Mei; Xia Feng; Mei-Rong Wan; Zhi Chen; Nicole Pavio; Christian Brechot
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

7.  Hepatitis C virus NS5B protein delays s phase progression in human hepatocyte-derived cells by relocalizing cyclin-dependent kinase 2-interacting protein (CINP).

Authors:  Yaohui Wang; Yuchan Wang; Yan Xu; Wenyan Tong; Tingting Pan; Jianhua Li; Shuhui Sun; Junjie Shao; Huanping Ding; Tetsuya Toyoda; Zhenghong Yuan
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

8.  Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.

Authors:  Wenbo Zhu; Chunchen Wu; Wanyu Deng; Rongjun Pei; Yun Wang; Liang Cao; Bo Qin; Mengji Lu; Xinwen Chen
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

9.  Hepatitis C virus core protein down-regulates p21(Waf1/Cip1) and inhibits curcumin-induced apoptosis through microRNA-345 targeting in human hepatoma cells.

Authors:  Tzu-Yue Shiu; Shih-Ming Huang; Yu-Lueng Shih; Heng-Cheng Chu; Wei-Kuo Chang; Tsai-Yuan Hsieh
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

10.  Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes.

Authors:  Kathie-Anne Walters; Andrew J Syder; Sharon L Lederer; Deborah L Diamond; Bryan Paeper; Charles M Rice; Michael G Katze
Journal:  PLoS Pathog       Date:  2009-01-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.